Okta's Q4 2025 earnings call reveals strong financial performance, exceeding analysts' estimates. A comparative analysis also pits Okta against SentinelOne. Read more...

Recent stock market activity includes changes in holdings for Wingstop, increased short interest in Alto Ingredients and Amalgamated Financial, and analyst upgrades for Okta and Roivant Sciences. Read more...

Recent analyst reports show mixed outlooks for Kimbell Royalty Partners, Sempra, Myriad Genetics, and Okta, with revised price targets and ratings. Read more...

A look at recent stock market activity, including analyst ratings for Okta, a short interest update for Adicet Bio, and comparisons of SEALSQ vs. Kopin and Primega Group vs. Tutor Perini. Read more...

Citigroup faces scrutiny after an $81 trillion error and fluctuating analyst ratings for stocks like Abbott Labs, Bio-Techne, Thermo Fisher, Mettler-Toledo, and Okta. Read more...

A summary of recent analyst ratings adjustments for various companies, including Agilysys, GitLab, Sphere Entertainment, Talos Energy, and Okta, highlighting potential upsides and downsides. Read more...

Mutual of America Capital Management adjusted its holdings in Cincinnati Financial and Expedia Group, while Barclays raised Okta's price target and ASML Holding saw a drop in short interest. Read more...

Okta (OKTA) receives multiple analyst upgrades and price target increases from firms like KeyCorp, DA Davidson, Mizuho, and Goldman Sachs, signaling strong market confidence. Read more...